These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 1100948)
41. Antileprosy drugs, pregnancy and fetal outcome. Bhargava P; Kuldeep CM; Mathur NK Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):457-8. PubMed ID: 9030117 [No Abstract] [Full Text] [Related]
42. The drug treatment of leprosy. Browne SG Practitioner; 1975 Oct; 215(1288):493-500. PubMed ID: 1202470 [No Abstract] [Full Text] [Related]
43. Critical comments on the treatment of leprosy and other mycobacterial infections with clofazimine. Freerksen E; Seydel JK Arzneimittelforschung; 1992 Oct; 42(10):1243-5. PubMed ID: 1472145 [TBL] [Abstract][Full Text] [Related]
44. [Indications for the use of lamprene in the treatment of leprosy]. Browne SG Acta Leprol; 1986; 4(4):409-11. PubMed ID: 3296610 [No Abstract] [Full Text] [Related]
45. The chemotherapy of leprosy. Part 1. Ellard GA Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):704-16. PubMed ID: 2280120 [No Abstract] [Full Text] [Related]
47. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity. Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255 [TBL] [Abstract][Full Text] [Related]
48. Efficacy of WHO regimens in the management of leprosy patients with G6PD deficiency. Mysore V; al-Suwaid AR Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):159-61. PubMed ID: 10472369 [No Abstract] [Full Text] [Related]
49. Effects of clofazimine alone or combined with dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy. van Rensburg CE; Gatner EM; Imkamp FM; Anderson R Antimicrob Agents Chemother; 1982 May; 21(5):693-7. PubMed ID: 7049077 [TBL] [Abstract][Full Text] [Related]
50. [Clofazimine and the eye]. Negrel AD; Baquillon G; de La Panouse A; Ducam M; Bagadec R; Chovet M Acta Leprol; 1981; (84):31-7. PubMed ID: 6797221 [No Abstract] [Full Text] [Related]
51. Multidrug therapy regimen for leprosy. Firooz A J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233 [No Abstract] [Full Text] [Related]
53. [Combined treatments consisting of rifampicin in periodic doses: the experience in Niger]. Soga G; Blanc L; Alfa C; Grosset J; Xavier S Acta Leprol; 1986; 4(4):397-407. PubMed ID: 3296609 [No Abstract] [Full Text] [Related]
54. Intra-neural ceroid-like pigment following the treatment of lepromatous leprosy with clofazimine (B663; Lamprene). McDougall AC; Jones RL J Neurol Neurosurg Psychiatry; 1981 Feb; 44(2):116-20. PubMed ID: 6260900 [TBL] [Abstract][Full Text] [Related]
55. A controlled clinical trial of continuous and intermittent rifampicin therapy during an initial three months period in lepromatous leprosy: final analysis. Pattyn SR; Rollier MT; Rollier R; Saerens EJ; Dockx P Lepr Rev; 1975 Jun; 46(2 Suppl):129-39. PubMed ID: 1100953 [No Abstract] [Full Text] [Related]